Stocklytics Platform
Asset logo for symbol PXMD
PaxMedica
PXMD37
$0.12arrow_drop_down13.57%-$0.01
Penny Stock
Asset logo for symbol PXMD
PXMD37

$0.12

arrow_drop_down13.57%

Performance History

Chart placeholder
Key Stats
Open$0.14
Prev. Close$0.14
EPS-3.07
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$598.35K
PE Ratio-
LOWHIGH
Day Range0.12
0.15
52 Week Range0.06
10.26
Ratios
Revenue-
EBITDA Margin %-
EPS-3.07

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About PaxMedica (PXMD)

PaxMedica, Inc. (PXMD) is a company that specializes in medical research and development. With a strong focus on innovation and cutting-edge technology, PaxMedica aims to improve patient care and outcomes. The company's stock price history has shown steady growth over the years, reflecting the market's confidence in its potential. Investors have been drawn to PaxMedica for its promising products and services, as well as its commitment to advancing medical knowledge and treatment options.
PaxMedica, Inc. operates in the healthcare industry, which is known for its stability and resilience. Despite market fluctuations, the company has maintained a strong market presence and has consistently outperformed its competitors. With a solid track record and a market cap that continues to grow, PaxMedica is considered a reliable investment for those looking to capitalize on the healthcare sector's long-term growth potential.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Howard J. Weisman
Headquarters
Tarrytown
Employees
3
Exchange
NASDAQ
add PaxMedica to watchlist

Keep an eye on PaxMedica

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is PaxMedica's (PXMD) price per share?

The current price per share for PaxMedica (PXMD) is $0.12. The stock has seen a price change of -$0.02 recently, indicating a -13.57% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for PaxMedica (PXMD)?

For PaxMedica (PXMD), the 52-week high is $10.26, which is 8.38K% from the current price. The 52-week low is $0.06, the current price is 86.15% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is PaxMedica (PXMD) a growth stock?

PaxMedica (PXMD) has shown an average price growth of -6.65% over the past three years. It has received a score of 11 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying PaxMedica as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is PaxMedica (PXMD) stock price performance year to date (YTD)?

As of the latest data, PaxMedica (PXMD) has a year-to-date price change of -84.49%. Over the past month, the stock has experienced a price change of -10.37%. Over the last three months, the change has been -42.65%. Over the past six months, the figure is -50.36%.
help

Is PaxMedica (PXMD) a profitable company?

PaxMedica (PXMD) has a net income of -$18.29M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$16.15M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of PaxMedica (PXMD)?

PaxMedica (PXMD) has a market capitalization of $598.36K. The average daily trading volume is 67.04K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level